Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000490652 | SCV000627275 | pathogenic | Osteogenesis imperfecta type I | 2025-01-27 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg220*) in the COL1A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL1A1 are known to be pathogenic (PMID: 7942841, 9295084, 9443882). This variant is present in population databases (rs72667036, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with osteogenesis imperfecta type 1 (PMID: 9443882, 18311573, 21667357, 22206639, 26627451). ClinVar contains an entry for this variant (Variation ID: 425637). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV001552353 | SCV001773023 | pathogenic | not provided | 2022-05-02 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26627451, 22753364, 30984112, 24501682, 31414283, 32581362, 25944380, 9443882, 21667357, 22206639, 18311573, 34107839, 31447884) |
Genome Diagnostics Laboratory, |
RCV002279256 | SCV002564746 | pathogenic | Osteogenesis imperfecta | 2019-08-01 | criteria provided, single submitter | clinical testing | |
MGZ Medical Genetics Center | RCV000490652 | SCV002579231 | pathogenic | Osteogenesis imperfecta type I | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Department of Medical Sciences, |
RCV000490652 | SCV000574638 | pathogenic | Osteogenesis imperfecta type I | no assertion criteria provided | clinical testing | ||
NIHR Bioresource Rare Diseases, |
RCV001003534 | SCV001161860 | likely pathogenic | Ehlers-danlos syndrome, arthrochalasia type, 2 | no assertion criteria provided | research | ||
Autoinflammatory diseases unit, |
RCV004767298 | SCV005381992 | pathogenic | Stickler syndrome type 2 | 2024-10-02 | no assertion criteria provided | clinical testing |